One-shot, six-week heroin-withdrawal drug trialled

Researchers at Johns Hopkins have published results from a trial of a one-shot opiod-addiction drug that lasts for six weeks and prevents widthrawal symptoms.
Five opioid-dependent volunteers each received a single subcutaneous depot injection containing 58 mg of buprenorphine and were assessed for at least four weeks for signs and symptoms of opioid withdrawal, first residentially and then as outpatients. Depot buprenorphine appeared to provide effective relief from opioid withdrawal, with no participant requiring additional medication for withdrawal relief following depot administration.
Link (via Ambiguous)

Cory Doctorow

Upcoming appearances

* Feb 9, 2012, DeKalb, IL: Day of Doctorow, NIU
* Feb 10-12, 2012, Chicago, IL: Capricon 32
* Feb 13, 2012, Arlington, TX: UT Arlington College of Engineering Distinguished Speaker Series
* Feb 16, 2012, Victoria, BC: 13th Annual Privacy and Security Conference

Recent books:
* Context (essays)
* With a Little Help (short stories)
* For the Win (YA novel)
* Makers (adult novel)

Comments are closed.

Where not otherwise specified, this work is licensed under a Creative Commons License permitting non-commercial sharing with attribution. Boing Boing is a trademark of Happy Mutants LLC in the United States and other countries.